Cyclin pathway in oligodendrogliomas IDH mut and 1p/19q codeleted

被引：0

作者：

Salgado, M. A. Vaz ^{[1
]}

Sanchez, J. M. Sepulveda ^{[2
]}

Earl, J. ^{[3
]}

Perez, A. ^{[4
]}

Pian, H. ^{[5
]}

Ruano, Y. ^{[6
]}

Gutierrez, J. ^{[6
]}

Mena, A. Carrato ^{[1
]}

Ley, L. L. ^{[7
]}

Villamayor, M. ^{[1
]}

Lopez, V. ^{[1
]}

Delfrade, I. Martinez ^{[1
]}

Albarran, V. ^{[1
]}

Chamorro-Perez, J. ^{[1
]}

Rodriguez, D. I. Rosero ^{[8
]}

Moron, B. I. ^{[1
]}

Lain, A. H. ^{[9
]}

机构：

[1] Hosp Univ Ramon Cajal, Dept Med Oncol, Madrid, Spain

[2] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid, Spain

[3] Hosp Univ Ramon & Cajal, IRYCIS, Madrid, Spain

[4] Hosp Univ 12 Octubre, Neurosurg, Madrid, Spain

[5] Hosp Univ Ramon Cajal, Pathol, Madrid, Spain

[6] Hosp Univ 12 Octubre, Pathol, Madrid, Spain

[7] Hosp Univ Ramon Cajal, Neurosurg, Madrid, Spain

[8] Hosp Univ Ramon Cajal, Oncol, Madrid, Spain

[9] UCM Univ Complutense Madrid, Madrid, Spain

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1707

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

513P

引用

页码：S397 / S397

页数：1

共 50 条

[1] Clinical Outcomes of Reirradiation in IDH-Mutant Astrocytomas and 1p/19q Codeleted Oligodendrogliomas
Rudra, S.
Robinson, C. G.
Tsien, C.
Campian, J. L.
Ansstas, G.
Chicoine, M.
Rich, K.
Kim, A. H.
Huang, J.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E342 - E342
[2] Gliosarcoma arising from oligodendroglioma, IDH mutant and 1p/19q codeleted
Yasuda, Takayuki
Nitta, Masayuki
Komori, Takashi
Kobayashi, Tatsuya
Masui, Kenta
Maruyama, Takashi
Sawada, Tatsuo
Muragaki, Yoshihiro
Kawamata, Takakazu
NEUROPATHOLOGY, 2018, 38 (01) : 41 - 46
[3] A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas
Gilhodes, Julia
Meola, Adele
Cabarrou, Bastien
Peyraga, Guillaume
Dehais, Caroline
Figarella-Branger, Dominique
Ducray, Francois
Maurage, Claude-Alain
Loussouarn, Delphine
Uro-Coste, Emmanuelle
Cohen-Jonathan Moyal, Elizabeth
POLA Network
CANCERS, 2023, 15 (12)
[4] TRANSCRIPTION FACTOR NETWORKS OF OLIGODENDROGLIOMAS (IDH-MUTANT AND 1p/19q CODELETED) TREATED WITH ADJUVANT RADIOTHERAPY OR OBSERVATION INFORMS PROGNOSIS
So, Jonathan
Moraes, Fabio
Mamatjan, Yasin
Aldape, Kenneth
Zadeh, Gelareh
NEURO-ONCOLOGY, 2018, 20 : 226 - 226
[5] Oligodendrogliomas: relation of morphology to 1p/19q genotype
An, S.
Henriquez, N.
Puls, F.
Brandner, S.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2009, 35 : 11 - 12
[6] Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas?
Gadji, Macoura
Fortin, David
Tsanaclis, Ana-Maria
Drouin, Regen
CANCER GENETICS AND CYTOGENETICS, 2009, 194 (01) : 12 - 22
[7] PDGFR-a in 1p/19q LOH oligodendrogliomas
Hartmann, C
Xu, XD
Bartels, G
Holtkamp, N
Gonzales, IA
Tallen, G
Von Deimling, A
INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (06) : 1081 - 1082
[8] Cystathionine: A Spectroscopic Biomarker for 1p/19q Codeleted Gliomas
Lin, Alexander P.
RADIOLOGY, 2023, 308 (03)
[9] SURVEY OF THE PROGNOSTIC FACTORS IN 1p/19q CODELETED GLIOMAS
Hayashi, Saeko
Sasaki, Hikaru
Kimura, Tokuhiro
Nakamura, Takumi
Miwa, Tomoru
Hirose, Yuichi
Yoshida, Kazunari
NEURO-ONCOLOGY, 2013, 15 : 89 - 90
[10] Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas
Kreiger, PA
Okada, Y
Simon, S
Rorke, LB
Louis, DN
Golden, JA
ACTA NEUROPATHOLOGICA, 2005, 109 (04) : 387 - 392

← 1 2 3 4 5 →